Medical DevicesAmerican Psychiatric Association Endorses Commitment To Closing The Medicare "Doughnut Hole"
The American Psychiatric Association (APA) commended
the Senate Finance Committee, the Obama administration and the nation"s pharmaceutical
companies today for addressing the Medicare coverage gap in prescription drug plans for
America"s seniors.
The coverage gap, known as the Medicare "doughnut hole," excludes coverage for the annual
costs of prescription medications that exceed $2,700 but don"t reach $6,154, a gap that APA
president Alan Schatzberg called "an excessive burden to those over 65 and those who are
chronically disabled, including those suffering from mental illnesses."
Under the new agreement on the part of Congress and PhRMA, the largest organization
representing the pharmaceutical industry, drug companies will provide $80 billion to cover up to
50 percent of the cost of brand-name medications that fall through the gap in Medicare"s Part D
prescription program. The agreement is being discussed as part of the major health care reform
legislation being considered by Congress.
"Although this is a first step, it is a step in the direction of providing high-quality, affordable
health care to all Americans," Dr. Schatzberg said. "The APA recognizes that full prescription
coverage is an integral part of any meaningful health care reform and applauds the effort to
eliminate one of the most glaring deficiencies in Medicare."
"We hope to see this agreement take effect as part of a package that includes the comprehensive
and universal health care coverage that the American people need and deserve," Dr. Schatzberg
said.
American Psychiatric Association